NDC 69539-200
Deferasorox
Deferasirox
Deferasorox is a Oral Granule in the Human Prescription Drug category. It is labeled and distributed by Msn Laboratories Private Limited. The primary component is Deferasirox.
| Product ID | 69539-200_40154b92-b71c-4ccc-b959-99b5c1528d25 |
| NDC | 69539-200 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Deferasorox |
| Generic Name | Deferasirox |
| Dosage Form | Granule |
| Route of Administration | ORAL |
| Marketing Start Date | 2021-03-18 |
| Marketing Category | ANDA / |
| Application Number | ANDA214650 |
| Labeler Name | MSN LABORATORIES PRIVATE LIMITED |
| Substance Name | DEFERASIROX |
| Active Ingredient Strength | 360 mg/1 |
| Pharm Classes | Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Iron Chelating Activity [MoA], Iron Chelator [EPC] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2023-12-31 |